We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.49B
AUM Growth
+$387M
Cap. Flow
-$101M
Cap. Flow %
-1.83%
Top 10 Hldgs %
34.03%
Holding
100
New
2
Increased
18
Reduced
60
Closed
4

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$28.4M
2
MRNA icon
Moderna
MRNA
+$26.9M
3
OTEX icon
Open Text
OTEX
+$11.4M
4
CAE icon
CAE Inc
CAE
+$8.93M
5
BNS icon
Scotiabank
BNS
+$7.52M

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$31.6M
2
SAVE
Spirit Airlines, Inc.
SAVE
+$27.2M
3
T icon
AT&T
T
+$14.2M
4
CNQ icon
Canadian Natural Resources
CNQ
+$13M
5
MFC icon
Manulife Financial
MFC
+$12.8M

Sector Composition

Rank Sector Weight
1 Financials 31.47%
2 Communication Services 16.33%
3 Materials 11.56%
4 Energy 9.5%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
URTH icon
76
iShares MSCI World ETF
URTH
$8.14B
$984K 0.02%
7,400
– –
ING icon
77
ING
ING
$105B
$960K 0.02%
63,910
-3,319
-5% -$45.6K
HDB icon
78
HDFC Bank
HDB
$116B
$898K 0.02%
26,750
+6,950
+35% +$210K
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$818K 0.01%
1,720
– –
VTWO icon
80
Vanguard Russell 2000 ETF
VTWO
$16.8B
$568K 0.01%
7,000
– –
GOOGL icon
81
Alphabet (Google) Class A
GOOGL
$4.22T
$352K 0.01%
2,520
– –
VT icon
82
Vanguard Total World Stock ETF
VT
$80.6B
$334K 0.01%
3,250
-200
-6% -$19.2K
KMB icon
83
Kimberly-Clark
KMB
$32.8B
$331K 0.01%
2,725
+700
+35% +$84.6K
DUK icon
84
Duke Energy
DUK
$91.8B
$301K 0.01%
3,100
– –
MSFT icon
85
Microsoft
MSFT
$3.69T
$240K ﹤0.01%
638
– –
MGTX icon
86
MeiraGTx Holdings
MGTX
$1.23B
$230K ﹤0.01%
32,700
+10,000
+44% +$49.4K
NXPI icon
87
NXP Semiconductors
NXPI
$57.1B
$224K ﹤0.01%
+975
New +$196K
SPRY icon
88
ARS Pharmaceuticals
SPRY
$423M
$197K ﹤0.01%
36,000
– –
LYRA
89
DELISTED
LYRA THERAPEUTICS INC
LYRA
$167K ﹤0.01%
638
– –
CVE.WS
90
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$157K ﹤0.01%
13,514
-1,743
-11% -$23.7K
TCRX icon
91
TScan Therapeutics
TCRX
$21.8M
$121K ﹤0.01%
20,700
-11,700
-36% -$53.6K
CBIO
92
Crescent Biopharma
CBIO
$698M
$107K ﹤0.01%
453
– –
MLYS icon
93
Mineralys Therapeutics
MLYS
$2.56B
$98K ﹤0.01%
11,400
– –
OM icon
94
Outset Medical
OM
$59M
$73.3K ﹤0.01%
903
– –
PROK icon
95
ProKidney
PROK
$364M
$28.3K ﹤0.01%
15,900
– –
ATRA icon
96
Atara Biotherapeutics
ATRA
$94.8M
$8.97K ﹤0.01%
700
– –
ENB icon
97
Enbridge
ENB
$106B
– –
-7,650
Closed -$255K
MET icon
98
MetLife
MET
$62.4B
– –
-12,949
Closed -$815K
SAVE
99
DELISTED
Spirit Airlines, Inc.
SAVE
– –
-1,650,620
Closed -$27.2M
MDNA
100
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
– –
-120,000
Closed -$35.4K
1 2 3
4

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Letko, Brosseau & Associates held 100 positions worth $5.49B, up 7.6% from $5.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q4 2023 filing shows 2 new, 18 increased, 60 reduced and 4 closed positions. Its largest new stake was Moderna: 319,430 shares worth $31.8M. The largest sale was Celestica, an estimated $31.6M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q4 2023 buy was Moderna: 319,430 shares worth $31.8M.
  • Letko, Brosseau & Associates added most to Pfizer in Q4 2023, an estimated $28.4M increase.
  • Letko, Brosseau & Associates's biggest Q4 2023 reduction was Celestica, cutting an estimated $31.6M.
  • Letko, Brosseau & Associates fully exited Spirit Airlines, Inc. in Q4 2023, selling an estimated $27.2M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $5.49B portfolio in Q4 2023.
  • Letko, Brosseau & Associates opened 2 new positions and closed 4 in Q4 2023.
  • Letko, Brosseau & Associates's portfolio value rose 7.6% quarter-over-quarter to $5.49B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.